The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant accounted for an outsized share of U.S. recalls for pills that didn’t dissolve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback